EXTRA-STRENGTH AIM Drug Patent Profile
✉ Email this page to a colleague
When do Extra-strength Aim patents expire, and when can generic versions of Extra-strength Aim launch?
Extra-strength Aim is a drug marketed by Chesebrough Ponds and is included in one NDA.
The generic ingredient in EXTRA-STRENGTH AIM is sodium monofluorophosphate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium monofluorophosphate profile page.
Summary for EXTRA-STRENGTH AIM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Patent Applications: | 1,857 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EXTRA-STRENGTH AIM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for EXTRA-STRENGTH AIM
US Patents and Regulatory Information for EXTRA-STRENGTH AIM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chesebrough Ponds | EXTRA-STRENGTH AIM | sodium monofluorophosphate | GEL;DENTAL | 019518-002 | Aug 6, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chesebrough Ponds | EXTRA-STRENGTH AIM | sodium monofluorophosphate | PASTE;DENTAL | 019518-001 | Jun 3, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |